$RKLB

Beck Peter sold $286.4M of RKLB (indirect holdings)

Beck Peter (CEO) sold 3,275,779 indirectly-held shares of Rocket Lab Corp (RKLB) at an average of $87.43 ($81.59–$101.57, $286.41M total) across 24 trades over 2026-07-06 to 2026-07-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Beck Peter
Published Jul 9, 2026, 12:13 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 9, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

The newest actionable element is the disclosed magnitude and timing window of the sales (3,275,779 shares from 2026-07-06 to 2026-07-08) and the post-transaction share count (1,724,221).

02

Market read

Traders may adjust short-term sentiment or positioning around insider-selling headlines, but the 10b5-1 designation reduces fundamental interpretation.

03

What to watch

The filing reports indirect holdings and a range of sale prices; traders should avoid inferring a single directional view from the average price alone.

Relevance 8/10Novelty 6/10Timing: new Form 4 filed after-hours on 2026-07-08, covering sales from 2026-07-06 to 2026-07-08

Background

This is an SEC Form 4 insider transaction by Rocket Lab CEO Beck Peter, coded as an open-market sale with a stated pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab CEO Beck Peter sold $286.4M of RKLB shares via an open-market sale under a 10b5-1 plan, reducing holdings to 1,724,221.

Expected impact

Mild negative to neutral short-term sentiment impact; likely limited fundamental read-through given 10b5-1 pre-arrangement.

Evidence & confidence

The filing is a primary-source Form 4 showing a very large sale ($286.4M) across 24 trades, but it explicitly states a pre-arranged 10b5-1 plan, which reduces interpretive weight versus non-plan sales.

Market effects

Limited sector read-through; this is company-specific insider activity rather than a sector catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect liquidity planning rather than negative expectations, so the market reaction could be overstated.

Key entities

  • Rocket Lab Corp

    Subject of the Form 4 insider sale; CEO Beck Peter sold $286.4M of RKLB shares under a 10b5-1 plan.

  • Beck Peter

    CEO and officer/director who executed the open-market sale of RKLB shares via indirect holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBHigh

Rocket Lab (RKLB) Stock Drops After Neutron Rocket Launch Delay

Rocket Lab (RKLB) shares fell 7.9% during trading and 7.3% after-hours after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company's P/S ratio is 45.17, above historical and industry averages, reflecting high growth expectations. Insider selling totaled $683.3 million over the past year. Rocket Lab has a GF Score of 77/100, indicating strong financial health but weak profitability.

$RKLBMed

Rocket Lab pushes Neutron rocket's debut flight to 2027, shares fall

Rocket Lab announced a delay in the debut flight of its Neutron rocket to 2027, pushing back from the previously targeted fourth quarter of 2026. The news caused the company's shares to drop about 6% in extended trading. Neutron is a reusable medium-lift rocket aimed at competing for larger commercial and national-security missions. Recently, Rocket Lab secured a multi-year launch agreement for 20 missions with Tokyo-based Synspective.

$RKLBHigh

Why is Rocket Lab stock tumbling today?

Rocket Lab (RKLB) stock dropped 7.2% in after-hours trading after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company also faces insider-selling pressure and a challenging macro environment with rising Fed rate hike bets. The stock is down over 60% from its 52-week high.

$RKLBHigh

Rocket Lab Stock Stumbles Despite Big Space Ambitions

Rocket Lab USA (RKLB) shares fell 8% during and after trading due to CEO Peter Beck's planned stock sale, SpaceX funding concerns, and a delay in the Neutron rocket launch to 2027. Despite record Q2 revenue of $234M and a strong backlog, investors worry about integration risks and profitability. Analysts maintain a Strong Buy rating with a $104.44 price target.